财报披露
CytoMed Therapeutics(GDTC)04-25 04:25
$CytoMed Therapeutics(GDTC)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-015796 Act: 34 Size: 230 KB 网页链接
简介：CytoMed Therapeutics Ltd于2018年3月8日在新加坡注册成立。该公司是一家临床前生物制药公司，专注于利用该公司的专有技术创造用于治疗人类癌症的新型细胞免疫疗法。该公司新技术的开发灵感来自于现有CAR-T细胞在治疗血液恶性肿瘤方面的临床成功，以及将CAR-T原理应用于实体肿瘤治疗方面的当前临床局限性和商业挑战。
| 今开：2.13 | 昨收：2.13 |
| 最高：2.13 | 最低：2.12 |
| 涨停价： | 跌停价： |
| 总市值：24464800 |
CytoMed Therapeutics(GDTC)04-25 04:25
$CytoMed Therapeutics(GDTC)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-015796 Act: 34 Size: 230 KB 网页链接
CytoMed Therapeutics(GDTC)03-18 18:05
$CytoMed Therapeutics(GDTC)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010173 Act: 34 Size: 82 KB 网页链接
CytoMed Therapeutics(GDTC)04-26 03:35
$CytoMed Therapeutics(GDTC)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-015906 Act: 34 Size: 230 KB 网页链接
CytoMed Therapeutics(GDTC)04-23 05:35
$CytoMed Therapeutics(GDTC)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001493152-24-015594 Act: 34 Size: 18 MB 网页链接
CytoMed Therapeutics(GDTC)03-04 19:25
$CytoMed Therapeutics(GDTC)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-008640 Act: 34 Size: 55 KB 网页链接
雷递2023-05-12 21:35
雷递网 雷建平 5月12日
新细胞医学（CytoMed Therapeutics，股票代码为：GDTC）上个月在美国纳斯达克上市，发行241股，发行价为4美元，募资总额为965万美元。
截至目前，新细胞医学市值为3240万美元。
新细胞医学是一家临床前生物制药公司，专注于利用该公司的专有技术创造用于治疗人...查看全文
$CytoMed Therapeutics(GDTC)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-015906 Act: 34 Size: 230 KB 网页链接
$CytoMed Therapeutics(GDTC)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-015796 Act: 34 Size: 230 KB 网页链接
$CytoMed Therapeutics(GDTC)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001493152-24-015594 Act: 34 Size: 18 MB 网页链接
$CytoMed Therapeutics(GDTC)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010173 Act: 34 Size: 82 KB 网页链接
$CytoMed Therapeutics(GDTC)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-008640 Act: 34 Size: 55 KB 网页链接
$CytoMed Therapeutics(GDTC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-006596 Act: 34 Size: 79 KB 网页链接
$CytoMed Therapeutics(GDTC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-006597 Act: 34 Size: 88 KB 网页链接
$CytoMed Therapeutics(GDTC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-006595 Act: 34 Size: 84 KB 网页链接
$CytoMed Therapeutics(GDTC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-006594 Act: 34 Size: 107 KB 网页链接
$CytoMed Therapeutics(GDTC)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-004055 Act: 34 Size: 90 KB 网页链接